Alzghari Saeed K, Amin Zubair M, Chau Sophie, Fleming Steven W, Cho Kevin, Fung Victor
Gulfstream Genomics, Gulfstream Diagnostics.
Thomas J. Long School of Pharmacy & Health Sciences, University of the Pacific.
Cureus. 2017 Sep 12;9(9):e1679. doi: 10.7759/cureus.1679.
Synthetic opioid use continues to be a problem in the United States. New designer opioids continue to be released as "research chemicals" by vendors, leading to widespread use and potentially devastating consequences. U-49900 is a new synthetic opioid with limited clinical data available. Herein, we provide an overview of U-49900, the anecdotal accounts of U-49900 use that clinicians need to be made aware of, and a call for the federal government to take immediate action in curtailing the use of U-49900.
合成阿片类药物的使用在美国仍然是一个问题。新的合成阿片类药物不断被供应商作为“研究化学品”推出,导致其广泛使用并可能带来毁灭性后果。U-49900是一种临床数据有限的新型合成阿片类药物。在此,我们概述了U-49900、临床医生需要了解的关于U-49900使用的传闻,并呼吁联邦政府立即采取行动减少U-49900的使用。